Catalyst Capital Advisors LLC Penumbra Inc Transaction History

Catalyst Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$134.81 - $177.8 $11,728 - $15,468	-87 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$131.82 - $183.4 $3,163 - $4,401	24 Added 38.1%	87 $12,000
Q2 2019 Aug 08, 2019	BUY	$124.65 - $167.39 $7,852 - $10,545	63 New	63 $10,000
Q1 2019 May 08, 2019	SELL	$115.84 - $160.31 $5,328 - $7,374	-46 Closed	0 $0
Q4 2018 Feb 07, 2019	SELL	$113.42 - $156.48 $1,474 - $2,034	-13 Reduced 22.03%	46 $6,000
Q3 2018 Nov 08, 2018	BUY	$121.55 - $156.8 $2,431 - $3,136	20 Added 51.28%	59 $9,000
Q2 2018 Aug 07, 2018	BUY	$112.2 - $165.95 $1,346 - $1,991	12 Added 44.44%	39 $5,000
Q1 2018 May 18, 2018	BUY	$84.6 - $126.1 $2,284 - $3,404	27 New	27 $3,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.